Dose Response Trial of Pergolide for Cocaine Dependence - 1

Medical University of South Carolina (MUSC) logo

Medical University of South Carolina (MUSC)

Status and phase

Completed
Phase 3

Conditions

Cocaine-Related Disorders

Treatments

Drug: Pergolide

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000248
NIDA-08355-1
R01DA008355 (U.S. NIH Grant/Contract)
R01-08355-1

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.

Sex

All

Ages

21 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems